Skip to content

BDTX - Black Diamond Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchB

Black Diamond Therapeutics Inc

BDTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

B

BDTXBlack Diamond Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $4.94
52-wk low: $1.60
Prev close: $3.18
Mkt cap: $125.5M
Fwd P/E: 8.3x
Beta: 3.29

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$18.0M

JS
Jim Simons
Q2 2026 13F
$3.6M
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Reported Aug 5, 2026

Earnings came in 5.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 8.33
Market cap: $125M

Valuation

P/S2.11
P/B1.23

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: BDTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $125.49M
Beta: 3.29

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

2.1x

P/B

1.2x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-37.2%

$1.7M

position

MG

Man Group

Q1 2026 13F

$1.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for BDTX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.17+5.6%

-$0.18 expected

Next report

What the street expects next

-37.2%

ROA-19.1%

Growth

Beta3.29